LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against First Choice Healthcare Solutions, Inc. (“First Choice” or “the Company”) (OTC: FCHS) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission.
Investors who purchased the Company's shares between April 1, 2014 and November 14, 2018, inclusive (the "Class Period"), are encouraged to contact the firm before May 28, 2019.
If you are a shareholder who suffered a loss, click here to participate.
We also encourage you to contact Brian Schall, or Sherin Mahdavian, of the Schall Law Firm, 1880 Century Park East, Suite 404, Los Angeles, CA 90067, at 424-303-1964, to discuss your rights free of charge. You can also reach us through the firm's website at www.schallfirm.com, or by email at brian@schallfirm.com.
The class, in this case, has not yet been certified, and until certification occurs, you are not represented by an attorney. If you choose to take no action, you can remain an absent class member.
According to the Complaint, the Company made false and misleading statements to the market. First Choice hired Elite Stock Research, Inc. to inflate the price of the Company’s stock by touting it to investors using false promotions. First Choice’s former CEO, President, and Chairman of the Board of Directors, Christian Romandetti, Sr., participated in the scheme, and personally profited from unlawful paid promotion. The scheme violated the Company’s internal compliance policies, code of ethics, and disclosure policy. Based on these facts, the Company’s public statements were false and materially misleading throughout the class period. When the market learned the truth about First Choice, investors suffered damages.
Join the case to recover your losses.
The Schall Law Firm represents investors around the world and specializes in securities class action lawsuits and shareholder rights litigation.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and rules of ethics.
